We also identified that two NAD+-associated genes, PARP2 and SIRT6, are significantly prognostic for the survival (p < 0.05) of HCC patients via uni-variate and LASSO-Cox regression analyses. The gene discussed is PARP2; the disease is hepatocellular carcinoma.